New England Biolabs is a company founded in the mid-1970s as a collective of scientists dedicated to the development of innovative products for the 'life-science' industry and is a recognized world leader in the discovery, development and commercialization of recombinant and indigenous enzymes for genomic research.
NEB offers the largest selection of recombinant and indigenous enzymes for genomic research. In addition to restriction enzymes that make up the main part of the portfolio, the catalog also includes products related to PCR, gene expression, cell analysis, RNA analysis and epigenetics. Currently, NEB offers approximately 276 restriction enzymes, and as a recognized leader in this field, has earned a worldwide reputation for establishing the highest standards of value and quality.
